Physician profile
Larry Yip
NPI 1356777494
$1,108.31
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $355 · 2022: $491 · 2023: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $278.99 | 2021-2023 | Symtuza |
| Janssen Products, Lp | $208.78 | 2021-2022 | |
| Abbvie INC. | $147.88 | 2021-2023 | |
| Kci USA, INC. | $123.06 | 2023 | Activ.A.C. |
| Gilead Sciences, INC. | $94.41 | 2021 | |
| Viiv Healthcare Company | $70.29 | 2022 | |
| Glaxosmithkline, LLC. | $51.89 | 2022-2023 | Arexvy |
| Astrazeneca Pharmaceuticals Lp | $43.85 | 2022 | |
| Lilly USA, LLC | $26.71 | 2023 | Trulicity, Mounjaro |
| Kls-Martin L.P. | $25.19 | 2023 | |
| Novartis Pharmaceuticals Corporation | $22.34 | 2022 | |
| Eisai INC. | $14.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Yip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.